METHIONINE UPTAKE BY TUMOR-TISSUE - A MICROAUTORADIOGRAPHIC COMPARISON WITH FDG

被引:0
|
作者
KUBOTA, R
KUBOTA, K
YAMADA, S
TADA, M
TAKAHASHI, T
IWATA, R
TAMAHASHI, N
机构
[1] TOHOKU UNIV,INST AGING DEV & CANC,DEPT NUCL MED,SENDAI,MIYAGI,JAPAN
[2] TOHOKU UNIV,INST AGING DEV & CANC,DEPT RADIOL & PHARMACOL,SENDAI,MIYAGI,JAPAN
[3] TOHOKU UNIV,CTR CYCLOTRON & RADIOISOTOPE,SENDAI,MIYAGI,JAPAN
[4] CLUSTERECORE INST BIOL,SENDAI,MIYAGI,JAPAN
关键词
CANCER IMAGING; METHIONINE UPTAKE; FDG; MALIGNANCY;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
L-methyl-C-11-methionine (C-11-Met) and 2-deoxy-2-F-18-fluoro-D-glucose (F-18-FDG) are used for tumor diagnosis and treatment evaluation by PET. In order to examine the role of these tracers in cancer imaging, intratumoral properties of C-14-Met were studied and compared to those of F-18-FDG. Methods: The distribution of C-14-Met in various cellular elements of two different mouse malignant tumor tissues, MH134 and FM3A, was analyzed serially using microautoradiography within a period of 120 min after injection of the tracer. Results: Carbon-14-Met and F-18-FDG showed different distributions in tumor tissue. Carbon-14-Met uptake by the tumor was mostly by viable cancer cells. The uptake by macrophages and other cellular components was low. The uptake was higher in the highly proliferative tumor but did not reflect protein synthesis. The rapid and slow growing tumors demonstrated that C-14-Met uptake ratio was lower than that of F-18-FDG, reflecting de novo DNA synthesis ratio. Conclusion: Carbon-14-Met uptake represents the presence of viable cancer cells. Carbon-11-Met may be suitable for treatment evaluation of individual tumors but not growth rates of different tumors. Flourine-18-FDG reflects tumor-host immune system reaction and is an excellent tool for pretreatment evaluation of tumors and determination of tumor proliferative activity.
引用
收藏
页码:484 / 492
页数:9
相关论文
共 50 条
  • [21] RNA ISOLATION FROM SOLID TUMOR-TISSUE
    KITLINSKA, J
    WOJCIEROWSKI, J
    [J]. ANALYTICAL BIOCHEMISTRY, 1995, 228 (01) : 170 - 172
  • [22] MECHANISM OF ROOT TUMOR-TISSUE FORMATION AT MELOIDOGYNOSIS
    OKOPNYI, NS
    [J]. DOKLADY AKADEMII NAUK SSSR, 1979, 249 (05): : 1277 - 1280
  • [23] PENETRATION OF TUMOR-TISSUE BY ANTIBODIES AND OTHER IMMUNOPROTEINS
    SHOCKLEY, TR
    LIN, KE
    NAGY, JA
    TOMPKINS, RG
    DVORAK, HF
    YARMUSH, ML
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1991, 618 : 367 - 382
  • [24] ACCURACY OF CT SCANS IN IDENTIFYING TUMOR-TISSUE
    HITCHON, PW
    SCHELPER, RL
    BARLOON, T
    [J]. APPLIED NEUROPHYSIOLOGY, 1985, 48 (1-6) : 463 - 466
  • [25] TUMOR TARGETING - CONDITIONS FOR ANTIBODY ACCUMULATION IN SOLID TUMOR-TISSUE
    MATZKU, S
    KIRCHGESSNER, H
    TILGEN, W
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1985, 109 (02) : A35 - A35
  • [26] ISOLATION OF ACELLULAR TUMOR FILTRATE (ATF) FROM THE TUMOR-TISSUE
    MANOILOV, SE
    SHVEDOVA, VN
    FIRSOVA, VI
    KONDRATEVA, VF
    ORLOVA, EI
    CHELYADINA, LD
    LYUBASHEVSKY, MN
    GOROZHANKINA, IS
    [J]. VOPROSY ONKOLOGII, 1980, 26 (06) : 87 - 89
  • [27] INVITRO COMPARISON OF FDG, METHIONINE, AND THYMIDINE AS POSSIBLE PET TUMOR IMAGING AGENTS
    HIGASHI, K
    WAHL, RL
    [J]. RADIOLOGY, 1992, 185 : 109 - 109
  • [28] PLURIPOTENTIAL GERMINAL TUMOR-TISSUE AS A SOURCE OF TRANSPLANTABLE GRAFT TISSUE
    JENNINGS, MT
    [J]. APPLIED NEUROPHYSIOLOGY, 1984, 47 (1-2) : 51 - 56
  • [29] DISTRIBUTION OF SOMATOSTATIN RECEPTORS IN NORMAL AND TUMOR-TISSUE
    REUBI, JC
    KVOLS, L
    KRENNING, E
    LAMBERTS, SWJ
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (09): : 78 - 81
  • [30] PLACENTAL ALKALINE-PHOSPHATASE IN TUMOR-TISSUE AND SERUM
    MOSSNER, E
    PFLEIDERER, G
    DITTEL, KD
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1984, 22 (07): : 467 - 471